Black Diamond Therapeutics (BDTX) Balance Sheet: Assets & Liabilities

Black Diamond Therapeutics (BDTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Black Diamond Therapeutics reported total assets of $143.01M and total liabilities of $30.80M. Shareholders' equity was $112.21M, up 34.7% from $83.28M a year earlier. Total debt stood at $18.78M against $128.65M in cash and short-term investments, a net cash position of $109.87M. That puts debt-to-equity at 0.17, compared with 0.27 a year earlier.

Black Diamond Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Black Diamond Therapeutics, Inc. (BDTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	20.99	36.44	56.22	34.32	65.80	34.61	154.67	51.66	7.88
Short-Term Investments	107.66	62.14	75.18	88.49	143.99	280.46	0.00	0.00	0.00
Cash & Short-Term Investments	128.65	98.58	131.40	122.81	209.79	315.07	154.67	51.66	7.88
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.79	2.60	2.63	4.90	5.92	4.49	1.05	0.02	0.04
Total Current Assets	132.44	101.18	134.03	127.71	215.70	319.55	155.71	51.68	7.91
Non-Current Assets
Property, Plant & Equipment (Net)	9.67	20.40	23.71	27.38	30.74	8.79	0.16	0.13	0.10
Long-Term Investments	0.83	0.00	0.00	0.00	0.00	1.22	0.00	0.00	0.00
Other Non-Current Assets	0.07	1.07	0.82	1.17	1.24	1.33	2.42	0.01	0.01
Total Non-Current Assets	10.57	21.46	24.53	28.55	31.98	10.12	2.58	0.14	0.11
Total Assets	143.01	122.64	158.57	156.26	247.68	329.67	158.30	51.83	8.02
Current Liabilities
Accounts Payable	0.58	4.01	2.32	1.88	4.11	2.54	1.96	0.42	0.15
Short-Term Debt	3.71	3.40	3.11	2.84	0.32	2.09	0.00	0.00	0.00
Accrued Liabilities	15.15	16.57	14.21	10.54	19.22	10.63	-	-	-
Other Current Liabilities	11.44	13.16	14.21	10.54	19.22	9.59	2.90	2.16	2.08
Total Current Liabilities	15.73	20.57	19.65	15.26	23.64	14.22	4.86	2.58	2.23
Non-Current Liabilities
Long-Term Debt	15.07	18.78	22.19	25.30	28.14	7.69	0.00	60.77	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	200.59	4.02	12.47
Total Non-Current Liabilities	15.07	18.78	22.19	25.30	28.14	7.69	200.59	64.79	12.47
Total Liabilities	30.80	39.36	41.83	40.56	51.78	21.91	205.45	67.37	14.70
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-464.74	-487.11	-417.43	-334.99	-243.82	-118.22	-50.97	-15.71	-6.78
Accumulated Other Comprehensive Income	0.10	0.02	-0.03	-1.82	-0.41	0.61	0.00	-0.10	-0.06
Additional Paid-in Capital	576.84	570.36	534.19	452.50	440.13	95.69	3.81	-60.40	-12.24
Shares Outstanding	57.14	56.64	51.65	36.43	36.23	-	-	-	-
Total Stockholders' Equity	112.21	83.29	116.74	115.70	195.90	307.76	-47.16	-15.54	-6.68
Total Liabilities & Equity	143.01	122.64	158.57	156.26	247.68	329.67	158.30	51.83	8.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Black Diamond Therapeutics Balance Sheet

How much debt does Black Diamond Therapeutics have?

Black Diamond Therapeutics had total debt of $18.78M as of Dec 31, 2025, against $128.65M in cash and short-term investments. Its debt-to-equity ratio was 0.17. Total debt was $22.19M a year earlier.

What are Black Diamond Therapeutics's total assets?

Black Diamond Therapeutics reported total assets of $143.01M as of Dec 31, 2025, up 16.6% from $122.64M a year earlier. Total liabilities were $30.80M.

What is Black Diamond Therapeutics's shareholders' equity?

Black Diamond Therapeutics's shareholders' equity was $112.21M as of Dec 31, 2025, or about $1.96 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition